Clinical Trial Update: Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating total marrow irradiation with high-dose melphalan before autologous transplant in multiple myeloma; the study status is terminated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Multiple Myeloma | Phase 1 | Status: TERMINATED | Results posted: 2019-10-14